Hanmi Science Co., Ltd. (KRX:008930)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Wholesale Division			1.07T	990.06B	916.53B	824.25B	783.22B
Pharmaceutical Wholesale Division Growth			8.20%	8.02%	11.20%	5.24%	15.35%
Other Sectors			15.54B	4.52B	2.10B	2.30B	2.84B
Other Sectors Growth			243.58%	115.83%	-8.88%	-19.14%	3.00%
Unallocated Adjustments			-25.27B	-6.02B	-4.79B	-4.72B	-4.34B
Healthcare Business Division			120.12B	18.45B	-	-	-
Healthcare Business Division Growth			551.06%	-	-	-	-
Holding Sector			66.30B	39.04B	36.33B	35.55B	34.89B
Holding Sector Growth			69.84%	7.46%	2.19%	1.89%	29.36%
Total			1.25T	1.05T	950.16B	857.38B	816.62B
Total Growth			19.30%	10.09%	10.82%	4.99%	15.34%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea			1.21T	1.04T	944.34B	853.23B	811.45B
South Korea Growth			16.86%	9.81%	10.68%	5.15%	15.36%
People's Republic of China			33.86B	8.74B	5.82B	4.15B	5.15B
People's Republic of China Growth			287.40%	50.24%	40.02%	-19.39%	12.67%
Other			2.23B	317.79M	3.12M	-	11.55M
Other Growth			601.60%	10072.41%	-	-	262.39%
Total			1.25T	1.05T	950.16B	857.38B	816.62B
Total Growth			19.30%	10.09%	10.82%	4.99%	15.34%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 17, 2026

Data Sources Report a data error